Acurx Pharmaceuticals, Inc. Common Stock (ACXP) is a publicly traded Healthcare sector company. As of September 1, 2026, ACXP trades at $1.40 with a market cap of $6.23M and a P/E ratio of -0.26. ACXP moved -3.10% today. Year to date, ACXP is -49.28%; over the trailing twelve months it is -67.89%. Its 52-week range spans $1.31 to $21.00. Analyst consensus is buy with an average price target of $20.50. Rallies surfaces ACXP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for ACXP shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $1.40 |
| Market Cap | $6.23M |
| P/E Ratio | -0.26 |
| EPS | $-5.32 |
| Dividend Yield | 0.00% |
| 52-Week High | $21.00 |
| 52-Week Low | $1.31 |
| Volume | 106.75K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-7.97M |
| Gross Margin | 0.00% |
2 analysts cover ACXP: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $20.50.